Unknown PHASE3 INTERVENTIONAL NCT00002455

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts

Sponsor: Centro Oncologico de Excelencia

Conditions Breast Cancer Colorectal Cancer Melanoma (Skin)

Interventions Corynebacterium granulosum P40 adjuvant therapy

Updated 6 times since 2017 Last updated: Aug 6, 2013 Started: Apr 30, 1971

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Breast Cancer and Colorectal Cancer, this trial is ongoing. The trial is conducted by Centro Oncologico de Excelencia and has accumulated 6 data snapshots since 1971. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Apr 1971

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Oncologico de Excelencia

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manuel B. Gonnet, Argentina